tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Technical Analysis

101 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Inhibikase Therapeutics’s (IKT) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Inhibikase Therapeutics is a Sell.
Inhibikase Therapeutics’s (IKT) 20-Day exponential moving average is 1.43, while Inhibikase Therapeutics’s (IKT) share price is $1.56, making it a Buy.
Inhibikase Therapeutics’s (IKT) 50-Day exponential moving average is 1.53, while Inhibikase Therapeutics’s (IKT) share price is $1.56, making it a Sell.

Inhibikase Therapeutics (IKT) Pivot Points

Jul 24, 2024, 03:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.21
1.30
1.40
1.49
1.59
1.68
1.78
Fibonacci
1.30
1.37
1.42
1.49
1.56
1.61
1.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Inhibikase Therapeutics (IKT) Moving Averages

Jul 24, 2024, 03:17 AM
Period
Simple
Exponential
MA5
1.49Sell
1.48Buy
MA10
1.44Buy
1.45Buy
MA20
1.36Buy
1.43Buy
MA50
1.54Sell
1.53Sell
MA100
1.78Sell
1.66Sell
MA200
1.63Sell
1.66Sell
Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 1.45, while Inhibikase Therapeutics’s (IKT) share price is $1.56, making it a Buy.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 1.66, while Inhibikase Therapeutics’s (IKT) share price is $1.56, making it a Sell.
Inhibikase Therapeutics’s (IKT) stock price is $1.56 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 1.54, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.56 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 1.78, creating a Sell signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.56 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.63, creating a Sell signal.

Inhibikase Therapeutics (IKT) Technical Indicators

Jul 24, 2024, 03:17 AM
Name
Value
Implied Action
RSI (14)
52.19
Neutral
STOCH (9,6)
57.20
Neutral
STOCHRSI (14)
64.00
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
20.27
Neutral
Williams %R
-36.45
Buy
CCI (14)
62.76
Neutral
ATR (14)
0.17
-
Ultimate Oscillator
50.06
Neutral
ROC
19.35
Buy
Inhibikase Therapeutics’s (IKT) Relative Strength Index (RSI) is 52.19, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Trend Strength Indicator (ADX) is 20.27, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Commodity Channel Index (CCI) is 62.76, creating a Neutral signal.
Inhibikase Therapeutics’s (IKT) Price Rate of Change (ROC) is 19.35, creating a Buy signal.

FAQ

Is IKT a Buy, Hold, or Sell?
Based on IKT’s technical indicators, IKT is a Hold.
    What is IKT’s RSI (14)?
    IKT’s RSI (14) is 52.19, which suggests IKT is a Neutral.
      What is IKT’s MACD?
      IKT’s MACD is >-0.01, which suggests IKT is a Sell.
        What is IKT’s 5-day moving average?
        IKT’s 5-day moving average is 1.49, which suggests IKT is a Sell.
          What is IKT’s 20-day moving average?
          IKT 20-day moving average is 1.36, which suggests IKT is a Buy.
            What is IKT’s 50-day moving average?
            IKT’s 50-day moving average is 1.54, which suggests IKT is a Sell.
              What is IKT’s 200-day moving average?
              IKT’s 200-day moving average is 1.63, which suggests IKT is a Sell.
                What is IKT’s Williams % R (14)?
                IKT’s Williams % R (14) is -36.45, which suggests IKT is a Buy.
                  What is IKT’s CCI (14)?
                  IKT’s CCI (14) is 62.76, which suggests IKT is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis